APS

Aptose Biosciences Inc.

CA Healthcare Biotechnology

Latest week
3 Jul 2026
Close
2.400000
Fair value
2.204936
Next-week expectancy
Negative 40.71%
Sharemaestro

APS Chart Pack

Aptose Biosciences Inc.

Exchange
TOR
Latest week
3 Jul 2026
Close
2.400000
Fair value
2.204936
Next-week expectancy
Negative 40.71%
Generated
17 Jul 2026 17:41
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-03, APS rose 1.27%, moving from 2.37 to 2.40. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is 2.95 and has improved across the 12-week window. Market Dynamics is -0.79 on the latest week. Next-week expectancy is negative at 40.71% based on similar historical setup states.

Key Points

Week Ending
3 Jul 2026
Latest Close
2.40
12-Week Change
1.27%
Trend Signal
Active
Next-Week Expectancy
Negative 40.71%
Signal Weeks
10 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
2.95
Market Dynamics
-0.79

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
3 Jul 2026
Latest Close
2.40
12-Week Change
1.27%
Trend Signal
Active
Next-Week Expectancy
Negative 40.71%
Signal Weeks
10 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
2.95
Market Dynamics
-0.79

Over the latest 12 completed weeks ending 2026-07-03, APS rose 1.27%, moving from 2.37 to 2.40. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is 2.95 and has improved across the 12-week window. Market Dynamics is -0.79 on the latest week. Next-week expectancy is negative at 40.71% based on similar historical setup states.

Industry Peers

Canada equities in Biotechnology

Stock Exchange Week Open High Low Close Change
MSCL Satellos Bioscience Inc. TOR 10 Jul 2026 10.95 14.15 10.86 13.53 23.56%
BCT BriaCell Therapeutics Corp. TOR 10 Jul 2026 4.82 5.64 4.82 5.58 15.77%
MBX Microbix Biosystems Inc. TOR 10 Jul 2026 0.30 0.32 0.30 0.32 6.67%
HBP Helix BioPharma Corp. TOR 10 Jul 2026 1.43 1.45 1.25 1.44 0.70%
APLI Appili Therapeutics Inc. TOR 10 Jul 2026 0.02 0.02 0.01 0.02 0.00%
RVX Resverlogix Corp. TOR 10 Jul 2026 0.10 0.10 0.09 0.10 0.00%
EPRX Eupraxia Pharmaceuticals Inc. TOR 10 Jul 2026 9.68 10.05 9.02 9.46 -2.27%
FRX Fennec Pharmaceuticals Inc. TOR 10 Jul 2026 15.32 15.32 14.40 14.50 -5.35%
SVA Sernova Biotherapeutics Inc TOR 10 Jul 2026 0.14 0.14 0.13 0.13 -7.14%
MDNA Medicenna Therapeutics Corp. TOR 10 Jul 2026 0.40 0.41 0.36 0.37 -7.50%
CSCI COSCIENS Biopharma Inc. TOR 10 Jul 2026 9.18 14.80 8.10 8.10 -11.76%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.